Literature DB >> 15528365

Differential regulation of primary and secondary CD8+ T cells in the central nervous system.

Chandran Ramakrishna1, Stephen A Stohlman, Roscoe A Atkinson, David R Hinton, Cornelia C Bergmann.   

Abstract

T cell accumulation and effector function following CNS infection is limited by a paucity of Ag presentation and inhibitory factors characteristic of the CNS environment. Differential susceptibilities of primary and recall CD8+ T cell responses to the inhibitory CNS environment were monitored in naive and CD8+ T cell-immune mice challenged with a neurotropic coronavirus. Accelerated virus clearance and limited spread in immunized mice was associated with a rapid and increased CNS influx of virus-specific secondary CD8+ T cells. CNS-derived secondary CD8+ T cells exhibited increased cytolytic activity and IFN-gamma expression per cell compared with primary CD8+ T cells. However, both Ag-specific primary and secondary CD8+ T cells demonstrated similar contraction rates. Thus, CNS persistence of increased numbers of secondary CD8+ T cells reflected differences in the initial pool size during peak inflammation rather than enhanced survival. Unlike primary CD8+ T cells, persisting secondary CD8+ T cells retained ex vivo cytolytic activity and expressed high levels of IFN-gamma following Ag stimulation. However, both primary and secondary CD8+ T cells exhibited reduced capacity to produce TNF-alpha, differentiating them from effector memory T cells. Activation of primary and secondary CD8+ T cells in the same host using adoptive transfers confirmed similar survival, but enhanced and prolonged effector function of secondary CD8+ T cells in the CNS. These data suggest that an instructional program intrinsic to T cell differentiation, rather than Ag load or factors in the inflamed CNS, prominently regulate CD8+ T cell function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15528365     DOI: 10.4049/jimmunol.173.10.6265

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Promoting remyelination through cell transplantation therapies in a model of viral-induced neurodegenerative disease.

Authors:  Vrushali Mangale; Laura L McIntyre; Craig M Walsh; Jeanne F Loring; Thomas E Lane
Journal:  Dev Dyn       Date:  2018-09-06       Impact factor: 3.780

Review 2.  The pathogenesis of murine coronavirus infection of the central nervous system.

Authors:  Thomas E Lane; Martin P Hosking
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

3.  The Biology of Persistent Infection: Inflammation and Demyelination following Murine Coronavirus Infection of the Central Nervous System.

Authors:  Martin P Hosking; Thomas E Lane
Journal:  Curr Immunol Rev       Date:  2009-05-04

4.  MHC mismatch results in neural progenitor cell rejection following spinal cord transplantation in a model of viral-induced demyelination.

Authors:  Jason G Weinger; Brian M Weist; Warren C Plaisted; Suzi M Klaus; Craig M Walsh; Thomas E Lane
Journal:  Stem Cells       Date:  2012-11       Impact factor: 6.277

5.  Mouse hepatitis virus infection of the CNS: a model for defense, disease, and repair.

Authors:  Chris S Schaumburg; Katherine S Held; Thomas E Lane
Journal:  Front Biosci       Date:  2008-05-01

Review 6.  Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies.

Authors:  Brett S Marro; Caroline A Blanc; Jeanne F Loring; Michael D Cahalan; Thomas E Lane
Journal:  Expert Rev Neurother       Date:  2014-10       Impact factor: 4.618

7.  CXCR2 signaling and host defense following coronavirus-induced encephalomyelitis.

Authors:  Brett S Marro; Martin P Hosking; Thomas E Lane
Journal:  Future Virol       Date:  2012-04       Impact factor: 1.831

Review 8.  Chemokine CXCL10 and Coronavirus-Induced Neurologic Disease.

Authors:  Dominic Skinner; Brett S Marro; Thomas E Lane
Journal:  Viral Immunol       Date:  2018-08-15       Impact factor: 2.257

9.  IL-15 independent maintenance of virus-specific CD8(+) T cells in the CNS during chronic infection.

Authors:  Jun Zuo; Stephen A Stohlman; Gabriel I Parra; Cornelia C Bergmann
Journal:  J Neuroimmunol       Date:  2008-12-23       Impact factor: 3.478

Review 10.  The chemokine receptor CXCR2 and coronavirus-induced neurologic disease.

Authors:  Jason G Weinger; Brett S Marro; Martin P Hosking; Thomas E Lane
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.